
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
July 2004 Table of Contents
over 22 years ago
One World, One Voiceover 22 years ago
Pricing Climate Heats Up in US and Europeover 22 years ago
Stop Giving Away Your Secrets





